title: [Abiraterone: Overall survival benefit and subsidiary issues].
authors.affiliation: Hôpital Louis-Pasteur, service oncologie hématologie, 4, rue Claude-Bernard, 28630 Chartres-Le-Coudray, France. Electronic address: svignot@ch-chartres.fr.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Vignot
mesh_terms: D000736:Androstenes / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000736:Androstenes; D018931:Antineoplastic Agents, Hormonal; C089740:abiraterone